|
gptkbp:instanceOf
|
cancer staging system
|
|
gptkbp:alternativeTo
|
gptkb:FIGO_staging_system
gptkb:Ann_Arbor_staging_system
|
|
gptkbp:appliesTo
|
solid tumors
|
|
gptkbp:basisFor
|
clinical trials
cancer prognosis
treatment planning
|
|
gptkbp:compatibleWith
|
leukemia
central nervous system tumors
|
|
gptkbp:component
|
Lymph node involvement (N)
Metastasis (M)
Tumor size (T)
|
|
gptkbp:developedBy
|
gptkb:American_Joint_Committee_on_Cancer
gptkb:Union_for_International_Cancer_Control
|
|
gptkbp:firstPublished
|
1950s
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
TNM staging system
|
|
gptkbp:name
|
describes regional lymph node involvement
|
|
gptkbp:practicedWorldwide
|
true
|
|
gptkbp:stagingType
|
clinical staging
pathological staging
|
|
gptkbp:TDP
|
describes size and extent of primary tumor
|
|
gptkbp:updated
|
gptkb:AJCC_Cancer_Staging_Manual
gptkb:UICC_TNM_Classification_of_Malignant_Tumours
|
|
gptkbp:usedFor
|
cancer classification
|
|
gptkbp:usedIn
|
oncology
|
|
gptkbp:מטה
|
describes presence of distant metastasis
|
|
gptkbp:bfsParent
|
gptkb:FIGO_system
gptkb:FIGO_(for_gynecologic_sites)
|
|
gptkbp:bfsLayer
|
5
|